FDA Orange Book · active-ingredient family
Hydromorphone hydrochloride
Hydromorphone hydrochloride is approved as 7 brand and 22 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:HYDROMORPHONE HYDROCHLORIDE · NDA 217812
7
Brand (NDA)
22
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · capsule, extended release, injectable, solution, tablet, tablet, extended release
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| HYDROMORPHONE HYDROCHLORIDERLD | HIKMA | NDA 217812 | — | Dec 14, 2023 | |
| DILAUDIDRLD×7 | FRESENIUS KABI USA | NDA 019034 | AP | Jan 16, 2020 | |
| EXALGORLD×4 | SPECGX LLC | NDA 021217 | — | Mar 01, 2010 | |
| DILAUDIDRLD×3 | RHODES PHARMS | NDA 019892 | AB | Nov 09, 2007 | |
| DILAUDIDRLD | RHODES PHARMS | NDA 019891 | AA | Dec 07, 1992 | |
| HYDROMORPHONE HYDROCHLORIDE×5 | HOSPIRA INC | NDA 200403 | — | Mar 03, 2023 | |
| PALLADONE×4 | PURDUE PHARMA LP | NDA 021044 | — | Sep 24, 2004 |
Generic (ANDA) products (22)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| HYDROMORPHONE HYDROCHLORIDE×4 | HIKMA | ANDA 216899 | AP | Feb 09, 2024 | |
| HYDROMORPHONE HYDROCHLORIDE×4 | ASCENT PHARMS INC | ANDA 212133 | AB | Sep 23, 2020 | |
| HYDROMORPHONE HYDROCHLORIDE | GENUS | ANDA 207108 | — | Apr 22, 2020 | |
| HYDROMORPHONE HYDROCHLORIDE | HIKMA | ANDA 202159 | AP | Apr 27, 2018 | |
| HYDROMORPHONE HYDROCHLORIDE×3 | ASCENT PHARMS INC | ANDA 210506 | AB | Jan 17, 2018 | |
| HYDROMORPHONE HYDROCHLORIDE | ASCENT PHARMS INC | ANDA 210176 | AA | Oct 27, 2017 | |
| HYDROMORPHONE HYDROCHLORIDE×5 | OSMOTICA PHARM US | ANDA 205629 | AB | Jul 07, 2016 | |
| HYDROMORPHONE HYDROCHLORIDE×3 | AUROLIFE PHARMA LLC | ANDA 205814 | AB | May 13, 2016 | |
| HYDROMORPHONE HYDROCHLORIDE×4 | PADAGIS US | ANDA 204278 | AB | Apr 06, 2015 | |
| HYDROMORPHONE HYDROCHLORIDE×4 | ACTAVIS LABS FL INC | ANDA 202144 | — | May 12, 2014 | |
| HYDROMORPHONE HYDROCHLORIDE | RISING | ANDA 078228 | AP | Apr 14, 2010 | |
| HYDROMORPHONE HYDROCHLORIDE | RISING | ANDA 078261 | AP | Apr 14, 2010 | |
| HYDROMORPHONE HYDROCHLORIDE×3 | GENUS | ANDA 077471 | — | Dec 09, 2009 | |
| HYDROMORPHONE HYDROCHLORIDE×2 | HIKMA | ANDA 074597 | — | May 29, 2009 | |
| HYDROMORPHONE HYDROCHLORIDE | HOSPIRA INC | ANDA 078591 | AP | Jun 17, 2008 | |
| HYDROMORPHONE HYDROCHLORIDE×3 | SPECGX LLC | ANDA 076855 | AB | Sep 19, 2007 | |
| HYDROMORPHONE HYDROCHLORIDE×3 | NESHER PHARMS | ANDA 077311 | — | Nov 09, 2005 | |
| HYDROMORPHONE HYDROCHLORIDE | MPP PHARMA | ANDA 076723 | — | Oct 18, 2005 | |
| HYDROMORPHONE HYDROCHLORIDE | BARR | ANDA 076444 | — | Apr 25, 2003 | |
| HYDROMORPHONE HYDROCHLORIDE | HIKMA | ANDA 074653 | AA | Jul 29, 1998 | |
| HYDROMORPHONE HYDROCHLORIDE | HOSPIRA | ANDA 074598 | — | Jun 19, 1997 | |
| HYDROMORPHONE HYDROCHLORIDE | WATSON LABS | ANDA 074317 | — | Aug 23, 1995 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 9731082 | Apr 23, 2032 | in 5 yr 11 mo | Product |
| 9248229 | Mar 12, 2034 | in 7 yr 10 mo | Product |
Hydromorphone hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

